Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH

28.51

-0.47(-1.62%)

Updated at June 02 03:00PM

Currency In CNY

Valuation

Market Cap15.36B
Enterprise Value16.8B
P/E Ratio-12.34
PEG Ratio-0.68
Price/Sales Ratio15.29
Price/Book Ratio106.34
Enterprise/Revenue17.57
Enterprise/EBITDA-16

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-1.23
Operating Margin-1.17

Management Effectiveness

Return On Assets-0.2
Return On Equity-1.81

Income Statement

Revenue662.52M
Revenue/Share1.87
Gross Profit662.52M
EBITDA-860.38M
Net Income-970.18M
Diluted EPS-2.43

Balance Sheet

Total Cash1.49B
Total Cash/Share3.74
Total Debt3.19B
Total Debt/Equity29.86
Current Ratio0.88
Book Value Per Share0.73

Price History

52-Week Change14.41
52-Week High63.59
52-Week Low22.4
Moving Average 50 Days35.58
Moving Average 200 Days40.63

Statistics

Average Volume8.62M
Shares Outstanding399.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.02
Last Split FactorN/A
Last Split DateN/A